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HLA-DR Genotypes in Familial Rheumatoid Arthritis:
Increased Frequency of Protective and Neutral Alleles
in a Multicase Family
SZILVIA ZSILÁK, JÁNOS GÁL, LÁSZLÓ HODINKA, KATALIN RAJCZY, ATTILA BALOG, SÁNDOR SIPKA,
SÁNDOR BARÁTH, ANIKÓ KAPITÁNY, ERIKA ZILAHI, and ZOLTÁN SZEKANECZ
ABSTRACT. Objective. We describe a unique family where each of the 5 siblings in the second generation has
rheumatoid arthritis (RA). Two other members of the family have RA and systemic lupus erythe-
matosus (SLE), respectively. No members of previous generations in the family had documented
inflammatory arthritis. Due to the suspected genetic predisposition, HLA-DR genotypes were deter-
mined in the affected siblings and their parents, children, and grandchildren. We investigated the
possible role of various HLA-DR alleles in the evolution of RA in this multicase family.
Methods. HLA-DRB1* alleles were determined by polymerase chain reaction using the sequence-
specific primer–Olerup method.
Results. The most common alleles in the 6 persons with RA were HLA-DRB1*07 and DRB1*15,
which are known to be protective and neutral in RA. No patient or family member carried any HLA-
DR4 alleles.
Conclusion. HLA-DRB1*07 and DRB1*15 alleles are thought to be protective or neutral in RA.
However, the majority of RA patients in the family and nearly half of all family members carried
these alleles, suggesting a role of these genotypes in susceptibility to RA. No RA patient in this fam-
ily carried HLA-DR4 alleles. Thus, in our rare family with 6 RA cases, an unexpected genetic back-
ground may be involved in the increased susceptibility to inflammatory arthritis. (J Rheumatol
2005;32:2299–302)
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Susceptibility to and severity of rheumatoid arthritis (RA)
show a clear association with certain HLA-DR1, DR4, and
DR10 haplotypes1-3. In contrast, HLA-DR2 or DR7 geno-
types may be rather protective or neutral regarding develop-
ment of the disease2,3. In this series of cases we describe a
unique Hungarian family where autoimmune inflammatory
diseases show an extreme familial aggregation. Each of the
5 siblings representing the second generation has RA, while
2 of the third generation have RA and systemic lupus ery-
thematosus (SLE), respectively.
By determining HLA-DR genotypes, we investigated
whether alleles known to be involved in higher susceptibil-
ity to RA or other genotypes could account for the unex-
pected aggregation of 6 cases of RA and one of SLE within
one family.
MATERIALS AND METHODS
The family tree is shown in Figure 1. Ethnically, all members of the family
are Caucasians. Each patient with RA fulfilled the 1987 American College
of Rheumatology (ACR) classification criteria for RA4. In addition, the
diagnosis was confirmed by hand magnetic resonance imaging and deter-
mination of anti-cyclic citrullinated peptide (anti-CCP) autoantibody in the
patient (II/4) who fulfilled the criteria for RA and secondary Sjögren’s syn-
drome (SS), besides the possibility of SLE. Core sets of variables of remis-
sion criteria were measured regularly by ACR and European League
Against Rheumatism standards5,6. Rheumatoid factor (RF) was assessed by
immunoturbidimetry. Antinuclear antibodies (ANA) were measured by the
standard agglutination method. Antibodies to extractable nuclear antigens
(ENA: including anti-Sm, nRNP, SSA, SSB, ds-DNA, ss-DNA) were deter-
mined by counterimmunoelectrophoresis. Anti-CCP antibody was assessed
by ELISA. Radiographs of hands and feet were scored by the Larsen scor-
ing system7.
Genotyping was carried out in 30 family members altogether. Genomic
DNA from whole blood containing EDTA was extracted by standard tech-
niques (High Pure PCR Template Preparation Kit, Roche, Budaors,
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Hungary). HLA-DRB1 allelic variants were determined using polymerase
chain reaction amplification with sequence-specific primers (SSP) based on
the procedure of Zetterquist and Olerup (Olerup SSP DR-low resolution kit,
GenoVision, Oslo, Norway).
The major clinical laboratory characteristics of the individual cases are
shown in Tables 1 and 2.
RESULTS
Results of HLA-DR genotyping are illustrated in Figure 1.
None of the family members carried HLA-DRB1*04 alle-
les. However, HLA-DRB1*01 alleles were found in 8 fam-
ily members. Only 2 patients with RA (II/2, III/4) carried
this genotype.
Four of 6 patients with RA (II/1, II/4, II/5, II/6) carried
HLA-DRB1*15. HLA-DRB1*07 alleles were detected in
4/6 RA patients (II/1, II/2, II/5, III/4). Two of 6 RA patients
carried HLA-DRB1*03.
The patient with SLE (III/9) carried both the HLA-
DRB1*03 and the HLA-DRB1*07 alleles.
DISCUSSION
We describe 30 members of a rather unique family. Five sis-
ters of the second generation, and a male in the third gener-
ation have RA. In addition, another family member has
SLE. We performed HLA-DR genotyping of all 30 available
members of the family in order to assess the possible role of
certain HLA-DRB1 alleles in susceptibility to RA.
RA is strongly associated with HLA-DRB1 molecules
sharing a common amino acid sequence in their third hyper-
variable region called the shared epitope (SE)2,3.
In our multicase family, none of the 30 family members
carries HLA-DR4 alleles. The frequency of the HLA-
DRB1*01 allele is very low as well (8/30). Only 2/6 patients
with RA carried this allele. In our recent study in Hungarian
patients with RA, the frequency of HLA-DR4 alleles was
found to be significantly increased in the patients with RA
(31%) compared to controls (11%). HLA-DR1 alleles were
detected in 32.5% of RA patients compared to 18% of con-
trols8.
In agreement with other studies, our analysis showed that
familial history of RA was not predictive for the progression
of radiological damage1. Erosion was detectable in only one
of our patients (II/4).
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Figure 1. Family tree showing HLA-DR genotypes. *Died at age 3 months due to developmental anomalies. † Deceased.
Table 1. Clinical characteristics of patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
Age at Disease Onset/ Sex Radiographic Present Therapy DAS28, Interventions DR1+ DR4+ HLA-DR
Present age, yrs (Larsen) Score min/max Genotype
II/1, RA 25/56 F 8 MTX, SSZ 2.11/7.10 — Neg Neg 7/15
II/2, RA 24/54 F 21 MTX, LEF, MP 4.42/6.45 Left knee RSO Pos Neg 1/7
II/4, RA, SS* 39/50 F 29 LEF, MP 2.02/8.46 Right, left knee RSO Neg Neg 3/15
II/5, RA 21/39 F 1 MTX, SSZ, CQ, MP 2.86/5.67 — Neg Neg 7/15
II/6, RA 33/37 F 4 CQ, MP 5.59/6.00 — Neg Neg 3/15
III/4, RA 34/36 M 8 MTX, SSZ, MP 2.71/3.76 — Pos Neg 1/7
III/9, SLE 23/29 F — MP — — Neg Neg 3/7
CQ: chloroquine, LEF: leflunomide, MP: methylprednisone, MTX: methotrexate, RSO: radiosynoviorthesis, SSZ: sulfasalazine, DAS: Disease Activity Score.
* Secondary Sjögren’s syndrome.
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The most interesting finding was that the 2 most frequent
alleles among the patients were HLA-DRB1*15 and
DRB1*07. In our recent study, no differences were found
between single Hungarian patients with RA and controls
with regard to HLA-DR7 (20.4% vs 21.8%, respectively)
and DR15 (13.2% vs 14.5%) allele frequencies8. The HLA-
DRB1*15 allele was carried by 4/6 RA patients in this fam-
ily. The frequency of this allele is rather high when consid-
ering the whole family. Mattey, et al described an associa-
tion between HLA-DRB1*15 and secondary SS in patients
with RA9. Others have noted significantly increased fre-
quency of HLA-DRB1*15 allele among RA patients with
renal involvement10. In our study no patient had renal
involvement, and only patient II/4 had RA-associated SS.
The association of HLA-DR3 with primary SS in
Caucasians is well established11. Patient II/4, with RA asso-
ciated with secondary SS, carried both HLA-DR15 and
HLA-DR3 alleles. This result is in agreement with previous
reports, according to which the higher risk of primary SS
development was associated with the HLA-DRB1*15/
DRB1*03 heterozygote genotype12. In contrast, Gottenberg,
et al found no relationship between HLA and SS, provided
patients have no autoantibodies13. Formation of an anti-
Ro/SSA autoantibody response was positively associated
with HLA-DR15, while DR3 is associated with both anti-
Ro/SSA and anti-La/SSB synthesis12,13. Our seronegative
RA patient with secondary SS was found to be positive for
anti-SSA and anti-SSB together with an HLA genotype pre-
dictive of primary SS. This might suggest the possibility of
primary SS as a background to our patient’s symptoms.
However, considering the typical erosive type of her poly-
arthritis, and that she is anti-CCP-positive, the diagnosis
with RA and secondary SS seems to be appropriate. The
genotype of our patient II/6 is HLA-DRB1*15/DRB1*03 as
well. However, she has no subjective sicca symptoms, posi-
tive Schirmer test results, or anti-SSA/SSB autoantibodies.
Apart from these findings, a French team has shown that
allele HLA-DRB1*15 has a neutral effect on RA3.
The other most frequent allele regarding the RA patients
(4/6) and the whole family (18/30) was HLA-DRB1*07.
According to the findings of Reviron, et al14 and Sanchez,
et al15, the DRB1*07 allele may have a protective effect on
RA. Two of our RA patients (II/2, III/4) carried both the pre-
dictive HLA-DRB1*01 and the protective DRB1*07 allele,
suggesting that the predictive HLA-DR1 genotype may
overrule protective alleles. As well, the study of Gibert, et al
showed that genotypes with SE alleles were not associated
with the risk for RA when the second allele was protective3.
In this family most RA patients carried the HLA-
DRB1*07 and/or HLA-DRB1*15 alleles, which in respect
of RA are considered protective and neutral alleles, respec-
tively. In another study, we found no association between
these alleles and sporadic RA8. Moreover, as other autoim-
mune diseases — SLE and secondary SS — also appear in
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Table 2. Potential diagnostic findings of autoimmune inflammatory disorders in 6 patients with RA and one with SLE.
Patient
II/1 II/2 II/4 II/5 II/6 III/4 III/9
Morning stiffness ≥ 1h + + + + + + –
Arthritis of ≥ 3 joints area + + + + + + +
Arthritis of hand joints + + + + + + +
Symmetric arthritis + + + + + + +
Rheumatoid nodules – – + – – – –
Radiographic changes
Periarticular osteoporosis/erosion +/– +/– +/+ +/– +/– +/– –/–
Serum RF – + – – – – +
Other autoantibodies – ds-DNA Anti-CCP, ANA, – – – ANA, SSA,
SSA, SSB, ds-DNA, SSB, ds-DNA,
ss-DNA ss-DNA
Episodic/persistent arthritis –/+ –/+ –/+ –/+ –/+ –/+ –/+
Subjective SS/Schirmer test +/– –/– +/+ –/– –/– –/– +/–
Extraarticular manifestations* – – Leukopenia, anemia – – – Photosensitivity,
urticaria, oral
ulcers, myalgia,
lupus nephritis,
pericarditis
(pericardiac tamponade),
pleuritis, leukopenia,
thrombocytopenia,
lymphopenia, anemia
Diagnosis RA RA RA, SS RA RA RA SLE
* Extraarticular manifestations: pulmonary, cardiac, neurological, nephrological, skin, mucosal, serosal, muscular, gastrointestinal, vasculitis, Raynaud’s phe-
nomenon. SS: Sjögren’s syndrome, RF: rheumatoid factor.
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this family, HLA-DR7 and DR15 may also account for the
association of RA with other systemic disorders within one
family. Our study of this multicase family confirms that the
genetic background of sporadic and familial RA may differ,
and that the genetics of familial RA cannot be completely
explained by the “shared epitope” hypothesis.
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